Evaluation of Performance and Possible Clinical Impact of Rapid QMAC‐dRAST Antimicrobial Susceptibility Testing From Positive Blood Cultures in a Tertiary Hospital and Low Antimicrobial Resistance Setting
Dina Riihiaho,
Ville Pirhonen,
Annukka Pietikäinen,
Kaisu Rantakokko‐Jalava APMIS
· Wiley
· 2026-11-06
· DOI: 10.1111/apm.70279
Abstract
ABSTRACT This study evaluated QMAC‐dRAST for rapid antimicrobial susceptibility testing from positive blood cultures in a low‐resistance setting by assessing analytical accuracy, detection of key resistance mechanisms and potential to shorten time to effective therapy. We tested 181 isolates and compared QMAC‐dRAST results with disc diffusion, resolving discrepancies by broth microdilution and calculating categorical agreement (CA) and error rates according to ISO 20776‐1:2019. We analyzed potential clinical impact among 128 patients with bacteremia. Categorical agreement was 92% for Gram‐negative and 91% for Gram‐positive bacteria, with very major errors in 7% and 28% of resistant isolates, respectively. Performance was limited for several key antibiotics: cefotaxime showed high very major error rates, piperacillin–tazobactam resistance was overestimated and meropenem resistance was underestimated. QMAC‐dRAST system correctly detected most critical resistance mechanisms, including all MRSA and VRE isolates and, after user interpretation, 90% of carbapenemase‐producing Enterobacterales. QMAC‐dRAST could have markedly shortened time to effective therapy in 8% of patients, but one false MRSA result risked inappropriate escalation of therapy. In this low‐resistance setting, QMAC‐dRAST offered modest benefit over rapid species identification, while suboptimal performance for key antibiotics, the absence of cefuroxime from the panel, and workflow challenges limited its utility without further optimization.
Dina Riihiaho, Ville Pirhonen, Annukka Pietikäinen, Kaisu Rantakokko‐Jalava. Evaluation of Performance and Possible Clinical Impact of Rapid QMAC‐dRAST Antimicrobial Susceptibility Testing From Positive Blood Cultures in a Tertiary Hospital and Low Antimicrobial Resistance Setting. // APMIS. – 2026. – DOI: 10.1111/apm.70279. – URL: https://onlinelibrary.wiley.com/doi/10.1111/apm.70279?af=R
Dina Riihiaho, Ville Pirhonen, Annukka Pietikäinen, & Kaisu Rantakokko‐Jalava (2026). Evaluation of Performance and Possible Clinical Impact of Rapid QMAC‐dRAST Antimicrobial Susceptibility Testing From Positive Blood Cultures in a Tertiary Hospital and Low Antimicrobial Resistance Setting. APMIS. https://doi.org/10.1111/apm.70279
Dina Riihiaho, et al. “Evaluation of Performance and Possible Clinical Impact of Rapid QMAC‐dRAST Antimicrobial Susceptibility Testing From Positive Blood Cultures in a Tertiary Hospital and Low Antimicrobial Resistance Setting.” APMIS, 2026. doi:10.1111/apm.70279.
@article{Riihiaho2026,
title = {Evaluation of Performance and Possible Clinical Impact of Rapid QMAC‐dRAST Antimicrobial Susceptibility Testing From Positive Blood Cultures in a Tertiary Hospital and Low Antimicrobial Resistance Setting},
author = {Riihiaho, Dina and Pirhonen, Ville and Pietikäinen, Annukka and Rantakokko‐Jalava, Kaisu},
journal = {APMIS},
year = {2026},
doi = {10.1111/apm.70279},
url = {https://onlinelibrary.wiley.com/doi/10.1111/apm.70279?af=R}
}
The Relationship Between Headache and Sinonasal Disease Burden in Cystic FibrosisAllan R. Wang,
Rory J. Lubner,
Jakob L. Fischer,
Jess C. Mace,
Taylor R. Osborne,
Justin Hedvat,
Jeremiah A. Alt,
Todd E. Bodner,
Michael T. Chang,
Naweed I. Chowdhury,
Sei Y. Chung,
Patricia H. Eshaghian,
Yuqing A. Gao,
Anne Getz,
David A. Gudis,
Peter H. Hwang,
Ashoke Khanwalkar,
Adam J. Kimple,
Todd T. Kingdom,
Jivianne T. Lee,
Douglas A. Li,
Jayakar V. Nayak,
Jonathan B. Overdevest,
Zara M. Patel,
Katie Poch,
Rodney J. Schlosser,
Timothy L. Smith,
Kristine A. SmithInternational Forum of Allergy and Rhinology
· Immunology and Allergy
· 2026-11-19
ABSTRACT The skin microbiome is a diverse community of bacteria, fungi, archaea, and viruses colonizing the human skin and is thought to play an important role in skin health. Skin homeostasis and immunity are influenced by a dynamic...
ABSTRACT Background Allergic contact dermatitis (ACD) from glucose sensors has become increasingly common. Newer devices, such as FreeStyle Libre 3 (Abbott Diabetes Care, UK), have been developed to enhance performance and reduce skin...